Swift Approval, Full Evaluation Drug Act
Legislative Progress
Introduced
February 16, 2007
Latest Action
February 27, 2007
Primary Sponsor
Edward J. MarkeyDemocratic(MA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
56pct
11d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2008 · third_quarter · Health Issues
-H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; -H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; -H.R. 1494 / S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediatric medical devices; -H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; -H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; -H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; -H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; -H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; -H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; -S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; -S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; -S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; -S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; -S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; -S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; -H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; -H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; -H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; -S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; -H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; -H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; -H.R. 5839, "Safeguarding America's Pharmaceuticals Act of 2008", To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, regarding all provisions; -S. 334, "Healthy Americans Act", A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away, regarding all provisions; -H.R. 6381, "Medical Device Safety Act of 2008", To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions; -S. 438, "Fair Prescription Drug Competition Act", A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs, regarding all provisions; -S. 3408, "Comparative Effectiveness Research Act of 2008", A bill to amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes, regarding all provisions; -S. 1276, "Methamphetamine Production Prevention Act of 2008", A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices, regarding all provisions. -Proposed Rule (CMS-1403-P), Regarding revisions to Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions;
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,500,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · second_quarter · Health Issues
H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products; H.R. 5839, "To Amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs", regarding all provisions; S. 334, "A bill to provide affordable, guaranteed private health coverage that will make Americans healthier and can never be taken away", regarding all provisions; H.R. 6381, "To amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions; S. 438, "A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs", regarding all provisions.
Client expense: $1,700,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
H.R.1165, "Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act," regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals; H.R. 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007," regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision o mental health and substance-related disorder benefits under group health plans; H.R. 1494 / S. 830, "Pediactric Medical Device Safety and Improvement Act of 2007," regarding improving the process for the development of needed pediactric medical devices; H.R. 1956, "Patient Protection and Innovative Biologic Medicines Act of 2007," regarding amending the public Health Service Act to provide for the approval of similar biological products; H.R. 2193, "Animal Protection Accountability Improvement Act," regarding amending the Animal Welfare Act to increase the penalties for violations of such Act to prohibit the use of animals for marketing medical devices; H.R. 2349/ S. 1413, "Uterine Fibroid Research and Education Act of 2007," regarding providing for research and education with respect to uterine fibroids; H.R. 3333 / S. 1576, "Minority Health Improvement and Health Disparity Elimination Act," regarding amending the Public Health Services Act to improve the health and healthcare of racial and ethnic minority groups; H.R. 788 / S. 468, "Food and Drug Administration Safety Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; H.R. 2900, "Food and Drug Administration Amendments Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the use-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S. 1082, "Food and Drug Administration Revitalization Act," regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S. 1695, "Biologics Price Competition and Innovation Act of 2007," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosilimar products to promote innovation in the life sciences; S. 467, "Fair Access to Clinical Trials Act of 2007 or the 'FACT Act'," regarding amending the Public Health Services Act to expand clinical trials drug data bank; S. 558, "Mental Health Parity Act of 2007," regarding all provisions ; S. 628, "Critical Access to Health Information Technology Act of 2007," regarding improving grants for rural health information technology development activities; S. 993, "Pediatric Research Improvement Act," regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine; H.R. 3580, "Food and Drug Administration Amendments Act of 2007," regarding fees related to prescription drugs, medical devices, and food safety; H.R. 2419 / S. 2302, "Food and Energy Security Act of 2007," regarding marketing and financial assistance related to farming and food production; H.R. 5606 / S. 2029, "Physician Payments Sunshine Act of 2007," regarding amending Title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP; S. 2221, "Transparency in Medical Device Pricing Act of 2007," regarding amending Title XVIII of the Social Security Act to provide for the reporting of sales price data for implantable devices; H.R. 3043, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," regarding appropriations for the Department of Health and Human Services; H.R. 5629, "Pathway for Biosimilar Act," regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Health Issues
HR 1165, Swift Approval, Full Evaluation Drug Act or the 'SAFE Drug Act', regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals;
Client expense: $3,880,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2007 · mid_year · Health Issues
HR 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007,” regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; HR 1494 / S 830, “Pediatric Medical Device Safety and Improvement Act of 2007,” regarding improving the process for the development of needed pediatric medical devices; HR 1956, “Patient Protection and Innovative Biologic Medicines Act of 2007,” regarding amending the Public Health Service Act to provide for the approval of similar biological products; HR 2193, “Animal Protection Accountability Improvement Act,” regarding amending the Animal Welfare Act to increase the penalties for violations of such Act and to prohibit the use of animals for marketing medical devices; HR 2349 / S 1413, “Uterine Fibroid Research and Education Act of 2007,” regarding providing for research and education with respect to uterine fibroids; HR 3333 / S. 1576, “Minority Health Improvement and Health Disparity Elimination Act,” regarding amending the Public Health Service Act to improve the health and healthcare of racial and ethnic minority groups; HR 788 / S 468, “Food and Drug Administration Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; HR 2900, “Food and Drug Administration Amendments Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S 1082, “Food and Drug Administration Revitalization Act,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S 1695, “Biologics Price Competition and Innovation Act of 2007,” regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products and to promote innovation in the life sciences; S 467, “Fair Access to Clinical Trials Act of 2007 or the `FACT Act',” regarding amending the Public Health Service Act to expand the clinical trials drug data bank; S 558, “Mental Health Parity Act of 2007,” regarding all provisions; S 628, “Critical Access to Health Information Technology Act of 2007,” regarding providing grants for rural health information technology development activities; S 993, “Pediatric Research Improvement Act,” regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine. HR 1165, “Swift Approval, Full Evaluation Drug Act or the `SAFE Drug Act',” regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals;
Client expense: $3,820,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2007 · mid_year · Pharmacy
H.R. 1165, Swift Approval, Full Evaluation Drug Act of the "SAFE Drug Act"; (Provisions relating to drug safety.) H.R. 970, Gang Prevention and Effective Deterrence Act of 2005; (Provisions relating to bulk distribution of DXM) H.R. 780, The "Counterfeit Drug Prevention Act of 2007"; (Provisions relating to prevention of counterfeit drugs.)
Client expense: $2,082,850 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Health Issues
* H.R. 1232/S. 746, To establish a competitive grant program to build capacity in veterinary medical education and expand the workforce of veterinarians engaged in public health practice and biomedical research; Section 2. Competitive Grants; (Provisions relating to entire bill.) S. 438, Fair Prescription Drug Competition Act of 2007; (Sections relating to authorized generics.) H.R. Access to Life -Saving Medicine Act; (Relating to follow-on biologics) H.R. 1165, Swift Approval, Full Evaluation Drug Act of the "SAFE Drug Act"; (Provisions relating to drug safety.) S. 21, A bill to provide for homeland security grant coordination and simplification, and for other purposes; (Sections relating to access to women's health therapies.) H.R. 970, Gang Prevention and Effective Deterrence Act of 2005; (Relating to bulk distribution of DXM.) H.R. 780, Counterfeit Drug Prevention Act of 2007; (Relating to prevention of counterfeit drugs.) H.R. 1282, Medigap Access Improvement Act; (Provisions relating to MediGap and hemophilia patients.) S. 1082, Prescription Drug User Fee Amendments of 2007; (Relating to FDA user fees reauthorization.) Full House Energy & Commerce Committee Markup of Committee prints on: PDUFA, MDUFMA, PREA, BPCA, Drug Safety; (Relating to reauthorization fo FDA user fees and safety.) H.R. 4, Prescription Drug Negotiation Act of 2007; (Provisions concerning repealing non-interference in Medicare.) S. 316, the "Preserve Access to Affordable Generics Act"; (Provisions relating to patent settlements.) 15
Client expense: $2,082,850 · Firm income: Not reported
2007 · mid_year · Health Issues
H.R. 1688 All Healthy Children Act of 2007 S. 325 Health Partnership Act H.R. 15 National Health Insurance Act S. 1169 State Based Health Reform Act S. 1564 All Healthy Children Act of 2007 H.R. 1329 Guaranteed Access for SCHIP’s Target Population Act of 2007 S. 1221 Countdown to Coverage Act of 2007 H.R. 2639 Promoting Health for Future Generations Act of 2007 S. 273 Prescription Drug and Health Improvement Act of 2007 H.R. 2971 Health Care Accountability Act S. 1102 Part D Equity for Low Income Seniors Act of 2007 S. 1753 Health Workforce Act of 2007 S. 1455 National Health Information Technology and Privacy Advancement Act of 2007 S. 1218 Medicare for All Act H.R. 2034 Medicare for All Act S. 895 Children’s Health First Act H.R. 2995 Small Business Liability Reform Act of 2007 H.R. 1012 Small Business Growth Act of 2007 H.R. 1542 Healthy Families Act H.R. 1626 Family Health Care Accessibility Act of 2007 S. 733 Promoting Health Care Purchasing Cooperatives Act H.R. 2351 HealthCARE Act 2007 S. 40 National Insurance Act of 2007 H.R. 493 Genetic Information Nondiscrimination Act of 2007 S. 359 Genetic Information Nondiscrimination Act of 2007 H.R. 677 The Nursing School Capacity Act of 2007 S. 446 Nurse Education, Expansion, and Development Act 0f 2007 H.R. 772 Nurse Education, Expansion, and Development Act 0f 2007 S. 605 Allied Health Reinvestment Act S. 620 Community – Based Health Care Retraining Act H.R. 1279 Direct Support Professionals Fairness and Security Act of 2007 H.R. 1134 Physical Therapist Student Loan Repayment Eligibility Act of 2007 S. 718 Patient – Focused Critical Care Enhancement Act H.R. 1884 National Health Service Corps Improvement Act of 2007 Act H.R. 410 United States Physician Shortage Elimination Act S.224 Standards to Provide Educational Achievement for All Kids H.R. 325 Standards to Provide Educational Achievement for All Kids H.R. 2497 Fair and Reliable Medical Justice Act S. 1481 Fair and Reliable Medical Justice Act H.R. 1174 Healthy Hospitals Act of 2007 H.R. 378 Nurse and Patient Safety and Protection Act of 2007 H.R. 2123 Nurse Staff and Standards for Patient Safety and Quality Care Act of 2007 S. 628 Critical Access to Health Information Technology Act of 2007 S. 1408 Health Information Technology Act of 2007 S. 1577 Patient Safety and Abuse Prevention Act of 2007 S. 1693 Wired for Health Care Quality Act H.R. 2723 Children’s Healthcare Quality Act S. 1226 Children’s Healthcare Quality Act H.R. 1952 National Health Information Incentive Act of 2007 H. R. 2580 Help Efficient, Accessible, Low cost, Timely Healthcare (HEALTH) Act of 2007 S. 1364 Healthy Kids Act of 2007 S. 484 Enhancing Drug Safety and Innovation Act of 2007 H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007 S. 1082 Prescription Drug User Fee Amendments of 2007 H.R. 3014 Health Equity and Accountability Act of 2007 H.R. 1165 SAFE Drug Act S. 1023 “To amend Title XXI of the Social Security Act […]” S. 554 Act for our Kids H.R. 1200 American Health Security Act of 2007 H.R. 15 National Health Insurance Act S. 1224 Children’s Health Insurance Program (CHIP) Reauthorization Act of 2007 H.R. 1368 Personalized Health Information Act of 2007 H.R. 676 United States National Health Insurance Act H.R. 1459 “To improve Medicare beneficiary access […]” H.R. 2737 Health Care Relief Act of 2007 S. 1714 Small Business Children’s Health Education Act of 2007 S. 1198 HealthCARE Act of 2007 H.R. 1802 Keeping Small Business Healthy Act of 2007 H.R. 2626 Comprehensive HealthCARE Act of 2007 H.R. 2842 Children’s Health Protection Act of 2007 S. 95 Kids Come First Act of 2007 H.R. 1111 Kids Come First Act of 2007 H.R. 493 Genetic Information Non-Discrimination Act of 2007 H.R. 2948 Increased Access to Health Insurance Act of 2007 S. 158 Access to Affordable Health Care Act S. 358 Genetic Information Non-Discrimination Act of 2007 H.R. 1012 Small Business Growth Act of 2007 H.R. 2147 Health Kids Act of 2007 S. 1298 Healthy Businesses, Healthy Workers Reinsurance Act of 2007 S. 21 Prevention First Act H.R. 819 Prevention First Act H.R. 593 Children’s Health Insurance Promotion Act of 2007 H.R. 1666 Health Care Price Transparency Promotion Act of 2007 H.R. 2302 Health Insurance Affordability Act of 2007 H.R. 2359 SBA Entrepreneurial Development Programs Act of 2007 H.R. 2357 MediKids Health Insurance Act of 2007 S. 401 Keep Children Covered Act of 2007 S. 2512 Reducing Coverage Gaps for Kids Act of 2007 H.R. 2055 Improving Children’s Access to Health Care Act of 2007 S. 1213 Children’s Express Lane to Heath Coverage Act of 2007 S. 334 Healthy Americans Act S. 1019 Universal Healthcare Choice and Access Act H.R. 1535 Children's Health First Act S. 895 Children's Health First Act
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE